Transcriptomics

Dataset Information

Combination of dual JAK/HDAC inhibitor with regorafenib reduces tumor growth, metastasis, and regorafenib-induced toxicity in colorectal cancer


ABSTRACT: To evaluate the differential gene expression contributing to the efficacy of the combination treatment of JAK/HDAC inhibitor with regorafenib, compared to single drug treatment, we performed the RNA-sequencing

ORGANISM(S): Homo sapiens

PROVIDER: GSE252554 | GEO | 2024/07/17

REPOSITORIES: GEO